Pinnacle Family Advisors LLC Acquires New Holdings in Johnson & Johnson (JNJ)

Pinnacle Family Advisors LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,582 shares of the company’s stock, valued at approximately $209,000.

Several other hedge funds have also recently bought and sold shares of JNJ. Vanguard Group Inc. raised its stake in shares of Johnson & Johnson by 1.5% during the second quarter. Vanguard Group Inc. now owns 200,450,985 shares of the company’s stock worth $26,517,661,000 after purchasing an additional 3,023,110 shares during the last quarter. BlackRock Inc. raised its stake in shares of Johnson & Johnson by 2.6% during the second quarter. BlackRock Inc. now owns 174,073,764 shares of the company’s stock worth $23,028,219,000 after purchasing an additional 4,332,612 shares during the last quarter. State Street Corp raised its stake in shares of Johnson & Johnson by 4.3% during the first quarter. State Street Corp now owns 160,223,321 shares of the company’s stock worth $19,955,806,000 after purchasing an additional 6,656,371 shares during the last quarter. FMR LLC raised its stake in shares of Johnson & Johnson by 5.9% during the second quarter. FMR LLC now owns 27,237,648 shares of the company’s stock worth $3,603,268,000 after purchasing an additional 1,509,745 shares during the last quarter. Finally, Capital World Investors raised its stake in shares of Johnson & Johnson by 4.1% during the second quarter. Capital World Investors now owns 26,510,007 shares of the company’s stock worth $3,507,009,000 after purchasing an additional 1,050,000 shares during the last quarter. 65.89% of the stock is owned by institutional investors and hedge funds.

JNJ has been the subject of several analyst reports. Cowen set a $147.00 price target on Johnson & Johnson and gave the stock a “buy” rating in a research note on Thursday, August 24th. UBS restated an “underweight” rating on shares of Johnson & Johnson in a research note on Thursday, August 24th. BMO Capital Markets restated a “buy” rating and set a $145.00 price target on shares of Johnson & Johnson in a research note on Friday, September 1st. Vetr cut Johnson & Johnson from a “hold” rating to a “sell” rating and set a $130.49 price target for the company. in a research note on Monday, September 18th. Finally, Goldman Sachs Group cut Johnson & Johnson from a “neutral” rating to a “sell” rating and upped their price target for the stock from $125.00 to $130.00 in a research note on Wednesday, September 20th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $145.04.

Johnson & Johnson (NYSE JNJ) opened at $142.46 on Monday. The stock has a market capitalization of $382,721.66, a price-to-earnings ratio of 19.95, a price-to-earnings-growth ratio of 2.90 and a beta of 0.80. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02. Johnson & Johnson has a 52-week low of $110.76 and a 52-week high of $144.35.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.80 by $0.10. The firm had revenue of $19.65 billion during the quarter, compared to analysts’ expectations of $19.29 billion. Johnson & Johnson had a return on equity of 27.38% and a net margin of 21.28%. Johnson & Johnson’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.68 earnings per share. equities analysts expect that Johnson & Johnson will post 7.28 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th were given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.36%. The ex-dividend date of this dividend was Monday, November 27th. Johnson & Johnson’s payout ratio is 58.33%.

COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://sportsperspectives.com/2017/12/18/pinnacle-family-advisors-llc-acquires-new-holdings-in-johnson-johnson-jnj.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply